Middle East & Africa Immunohistochemistry Market Size & Outlook
Middle East & Africa immunohistochemistry market, 2018-2030 (US$M)
Related Markets
MEA immunohistochemistry market highlights
- The MEA immunohistochemistry market generated a revenue of USD 126.2 million in 2023.
- The market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
- In terms of segment, antibodies was the largest revenue generating product in 2023.
- Antibodies is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 126.2 million |
| Market revenue in 2030 | USD 192.2 million |
| Growth rate | 6.2% (CAGR from 2023 to 2030) |
| Largest segment | Antibodies |
| Fastest growing segment | Antibodies |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibodies, Reagents, Equipment, Kits |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG, Merck KGaA, Danaher Corp, PerkinElmer, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Abcam PLC, Cell Signaling Technology, Bio SB |
Other key industry trends
- In terms of revenue, MEA region accounted for 5.4% of the global immunohistochemistry market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 854.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunohistochemistry Market Scope
Immunohistochemistry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa immunohistochemistry market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunohistochemistry market will help companies and investors design strategic landscapes.
Antibodies was the largest segment with a revenue share of 41.2% in 2023. Horizon Databook has segmented the Middle East & Africa immunohistochemistry market based on antibodies, reagents, equipment, kits covering the revenue growth of each sub-segment from 2018 to 2030.
Key countries considered in MEA IHC market are South Africa, Saudi Arabia, and the UAE. High disease burden, increasing privatization of healthcare, and rising availability of health insurance are among the factors expected to positively influence MEA IHC market.
In addition, an increase in the number of government initiatives being undertaken to improve healthcare infrastructure in South Africa and other African countries is also expected to boost the demand for advanced IHC techniques for disease diagnosis.
Reasons to subscribe to Middle East & Africa immunohistochemistry market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa immunohistochemistry market databook
-
Our clientele includes a mix of immunohistochemistry market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa immunohistochemistry market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa immunohistochemistry market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA immunohistochemistry market size, by country, 2018-2030 (US$M)
Middle East & Africa Immunohistochemistry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
